Their compounding status under federal law is still being determined: removal from the Category 2 restricted list takes effect April 23, 2026, and the FDAs Pharmacy Compounding Advisory Committee will review whether to officially clear any of them at its July 23-24, 2026 meeting
This inhibition prevents the conversion of nicotinamide into 1-methylnicotinamide, effectively rescuing the NAD salvage pathway
Also, Wegovy must not be given to people with a personal or family history of multiple endocrine neoplasia syndrome type 2 (MEN 2) or medullary thyroid carcinoma (MTC)
They try the usual route, rest, rehab, time
They always say it
(the FDA has exempted many vitamins from formal categorization), but they are regarded as safe as part of a normal diet and necessary for fetal growth